Cited by 77HIV-related health complications and treatmentsTelomeres, Telomerase, and SenescenceHIV/AIDS drug development and treatment

Premature Senescence of Vascular Cells Is Induced by HIV Protease Inhibitors: Implication of Prelamin A and Reversion by Statin

Lefèvre, Chloé, Auclair, Martine, Boccara, Franck, Bastard, Jean-Philippe, Capeau, Jacqueline, Vigouroux, Corinne, Caron-Debarle, Martine·2010·Arteriosclerosis, Thrombosis, and Vascular Biology

Abstract

Objective— To determine whether and how protease inhibitors (PIs) could affect vascular aging. Methods and Results— HIV therapy with PIs is associated with an increased risk of premature cardiovascular disease. The effect of ritonavir and a combination of lopinavir and ritonavir (for 30 days) on senescence, oxidative stress, and inflammation was evaluated in human coronary artery endothelial cells (HCAECs). These HCAECs were either cotreated or not cotreated with pravastatin or farnesyl transferase inhibitor (FTI)-277 or with 2 antioxidants (manganese [III] tetrakis [4-benzoic acid] porphyrin [MnTBAP] and N-acetyl cysteine). Senescence markers were evaluated in peripheral blood mononuclear cells (PBMCs) from HIV-infected patients under PI treatment. PIs induced senescence markers, prelamin A accumulation, oxidative stress, and inflammation in HCAECs. Senescence markers and prelamin A were also observed in PBMCs from HIV-infected patients under ritonavir-boosted PIs. Pravastatin, FTI-277, and antioxidants improved PI adverse effects in HCAECs. Senescence markers were lower in PBMCs from PI-treated patients cotreated with statins. Conclusion— PIs triggered premature senescence in endothelial cells by a mechanism involving prelamin A accumulation. Accordingly, circulating cells from HIV-infected patients receiving PI therapy expressed senescence markers and prelamin A. Statin was associated with improved senescence in endothelial cells and patient PBMCs. Thus, PIs might promote vascular senescence in HIV-infected patients; and statins might exert beneficial effects in these patients.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/atvbaha.110.213603

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Lefèvre, C., Auclair, M., Boccara, F., Bastard, J.-P., Capeau, J., Vigouroux, C., & Caron-Debarle, M.
Affiliations
  • From Institut National de la Santé et de la Recherche Scientifique (INSERM) (C.L., M.A., F.B., J.C., C.V., and M.C.-D.), Saint Antoine Research Center, Unité Mixte de Recherche (UMR) S 938, Faculté deMédecine Saint Antoine, Paris, France; Université Pierre et Marie Curie (UPMC) University Paris 06 (C.L., M.A., F.B., J.C., C.V., and M.C.-D.), Saint Antoine Research Center, UMR S 938, Paris, France; Assistance publique-Hopitaux de Paris (AP-HP), the Department of Cardiology (F.B.), Hopital Saint...
  • Inserm (FR)
Venue
Arteriosclerosis, Thrombosis, and Vascular Biology
Published
2010-12
Volume
30
Issue
12
Pages
2611-2620
ISSN
  • 1079-5642 (ISSN-L)
  • 1524-4636
OpenAlex
W2170777065
Cited by
77
References
49
Citations by year
2026: 2 · 2025: 4 · 2024: 3 · 2023: 1 · 2022: 3 · 2021: 4 · 2020: 5 · 2019: 3 · 2018: 4 · 2017: 8 · 2016: 8 · 2015: 3 · 2014: 11 · 2013: 9 · 2012: 5
FWCI
5.48
Type
journal article
Language
en
Open access
closed
Locations
  • Arteriosclerosis Thrombosis and Vascular Biology (publishedVersion)
  • PubMed (publishedVersion)
Funders
Styrelsen för Internationellt Utvecklingssamarbete
Topics
  • Health Sciences › Medicine › Emergency Medicine › HIV-related health complications and treatments
  • Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
Keywords
HIV protease inhibitors, premature senescence, vascular aging, endothelial cells, ritonavir, lopinavir, oxidative stress, inflammation, statins, pravastatin, farnesyltransferase inhibitors, antioxidants, cardiovascular risk, people living with HIV
MeSH terms
Acetylcysteine, Adult, Antioxidants, Cells, Cultured, Coronary Vessels, Drug Therapy, Combination, Humans, Metalloporphyrins, Methionine, Middle Aged, Nuclear Proteins, Paris, Protein Precursors, Pyrimidinones, Time Factors, HIV Infections, Case-Control Studies, Tumor Suppressor Protein p53, Cellular Senescence, Pravastatin, HIV Protease Inhibitors, Oxidative Stress, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Ritonavir, Lamin Type A, Endothelial Cells, Cell Proliferation, Cyclin-Dependent Kinase Inhibitor p21, Farnesyltranstransferase, Lopinavir

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review